Skip to content

Clinical trials

Completed Phase 2 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Status: Completed Clear all

522 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200027
200122
200229
200337
200434
200537
200644
200720
200830
200925
201020
201113
201213
201318
20148
201519
201612
201710
20188
20197
20208
20219
20223
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed522

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology33
M.D. Anderson Cancer Center24
Memorial Sloan Kettering Cancer Center23
SCRI Development Innovations, LLC18
SWOG Cancer Research Network17
National Cancer Institute (NCI)14
Radiation Therapy Oncology Group12
Eli Lilly and Company10
Novartis Pharmaceuticals10
Pfizer10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms522
Carcinoma, Non-Small-Cell Lung333
Adenocarcinoma of Lung65
Small Cell Lung Carcinoma51
Adenocarcinoma, Bronchiolo-Alveolar34
Breast Neoplasms25
Neoplasm Metastasis24
Neoplasms24
Head and Neck Neoplasms16
Pancreatic Neoplasms15

Trials

Showing 1 to 25 of 522. Each trial links to its page on Pharma Observatory.

422 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.